Group 1 - The company, Renhe Pharmaceutical (000650), stated on August 26 that it does not have information on the innovative drugs under research by Weimiao Biotechnology [1] - The collaboration between Weimiao Biotechnology and Renhe Pharmaceutical in the ophthalmology business will depend on the needs of both parties [1]